Profile
Dennis Yamashita worked as a Director at Oncology, Inc., a Principal at GlaxoSmithKline, Inc., and as Vice President & Head-Chemistry at Trevena, Inc. He received his undergraduate degree from Massachusetts Institute of Technology in 1986 and his doctorate degree from Yale University in 1991.
Former positions of Dennis Yamashita
Companies | Position | End |
---|---|---|
Oncology, Inc.
Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008. | Director/Board Member | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
TREVENA, INC. | Corporate Officer/Principal | - |
Training of Dennis Yamashita
Yale University | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TREVENA, INC. | Health Technology |
Private companies | 2 |
---|---|
Oncology, Inc.
Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dentsu Group, Inc., Oncology, Inc. provides oncology treatment information. The company is based in Cherry Hill, NJ. Oncology was acquired by Aegis Group Plc on January 07, 2008. | Commercial Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Dennis Yamashita